Association of the Promoter Methylation of Mitochondrial Transcription Factor A With Susceptibility to Metabolic Syndrome

AuthorMohammad Hashemien
AuthorHamzeh Rezaeien
AuthorMahmoud Ali Kaykhaeien
AuthorMohsen Taherien
OrcidMohammad Hashemi [0000-0002-6074-7101]en
Issued Date2014-04-01en
AbstractBackground: It has been proposed that the patients with mitochondrial diseases usually manifest systemic metabolic disorders. The metabolic syndrome (MeS), a cluster of several metabolic disorders, is increasingly being recognized as a risk factor for type 2 diabetes (T2D) and cardiovascular disease. Objectives: The aim of study was to investigate the possible association between promoter methylation of mitochondrial transcription factor A (TFAM) and MeS. Patients and Methods: DNA was extracted from peripheral blood of 151 patients with and 149 without MeS. Results: TFAM promoter methylation was evaluated by a nested methylation-specific PCR (nested MSP). Conclusions: No association was found between TFAM promoter methylation and MeS. The present study suggests that the TFAM promoter methylation is not associated with risk of MeS.en
DOIhttps://doi.org/10.17795/gct-18308en
KeywordMetabolic Syndrome Xen
KeywordMitochondrial Transcription Factor Aen
KeywordDiabetes Mellitusen
KeywordType 2 DMen
PublisherBrieflandsen
TitleAssociation of the Promoter Methylation of Mitochondrial Transcription Factor A With Susceptibility to Metabolic Syndromeen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
15122-pdf.pdf
Size:
109.65 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF